Stanford Trial Tests Prenatal Treatment for Rare Disease
Expectant parents can now enroll in a groundbreaking trial that treats Fanconi anemia before birth, potentially preventing devastating complications without harsh side effects. Stanford researchers are infusing healthy stem cells from mothers to their babies in the womb.
